AnnLaCasceMD

PubMed

• Advancements in the Management of Follicular Lymphoma: A Comprehensive Review.
  Özgür Mehtap, Reid Merryman, Ann LaCasce> ;Turkish Journal of Haematology. 2024 Apr 25
• Brentuximab Vedotin and Chemotherapy in Relapsed/Refractory Hodgkin Lymphoma: a Propensity Score Matched Analysis.
  Julia Driessen, Fer de Wit, Alex F Herrera, Pier Luigi Zinzani, Ann S LaCasce, Peter D Cole, Craig H Moskowitz, Ramón García-Sanz, Michael Fuchs, Horst Mueller, Peter ...> ;Blood Advances. 2024 Mar 19
• Frontline Treatment of Mantle Cell Lymphoma.
  Christine E Ryan, Philippe Armand, Ann S LaCasce> ;Blood. 2024 Mar 18
• Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL.
  Ahn, I., Brander, D., Ren, Y., Zhou, Y., Tyekucheva, S., Walker, H., Black, R., Montegaard, J., Alencar, A., Shune, L., Omaira, M., Jacobson, C., Armand, P., Ng, S., C...> ;Blood Advances. 2024 Feb 27
• Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP.
  Nemec, R., Scherrer-Crosbie, M., Abramson, J., Redd, R., Gilman, H., Ho, T., Wu, J., Heemelaar, J., Neuberg, D., Hochberg, E., Barnes, J., Armand, P., Jacobsen, E., Ja...> ;Leukemia & Lymphoma. 2024 Feb 21
• Evaluation of mediastinal lymph node segmentation of heterogeneous CT data with full and weak supervision.
  Mehrtash, A., Ziegler, E., Idris, T., Somarouthu, B., Urban, T., Van Den Abbeele, A., Pieper, S., Harris, G., Kikinis, R., Kapur, T., LaCasce, A., Jacene, H.> ;Computerized Medical Imaging and Graphics. 2024 Jan 1
• Classic Hodgkin lymphoma.
  Justine Kahn, Bouthaina Dabaja, Susan Wu, Kara Kelly, Leanne Berkahn, Astrid Pavlovsky, Anna Sureda, Ann LaCasce> ;Hematological Oncology. 2023 Dec 1
• 4 citations
  NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
  Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, Ranjana H Advani, Babis Andreadis, Nancy L Bartlett, L Elizabeth Budde, Paolo F Caimi, Julie E Chang, Beth Christia...> ;Journal of the National Comprehensive Cancer Network. 2023 Nov 1
• A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma.
  Reid W Merryman, Robert A Redd, Arnold S Freedman, Inhye E Ahn, Jennifer R Brown, Jennifer L Crombie, Matthew S Davids, David C Fisher, Eric D Jacobsen, Austin I Kim, ...> ;Annals of Hematology. 2024 Jan 1
• Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1.
  Howland E Crosswell, Ann S LaCasce, Nancy L Bartlett, David J Straus, Kerry J Savage, Pier Luigi Zinzani, Graham P Collins, Michelle Fanale, Keenan Fenton, Cassie Dong...> ;Haematologica. 2024 Mar 1
• 1 citations
  Author gender representation of journal reviews and editorials on lymphoma (2017-22).
  Eliza A Hawkes, Judith Trotman, Carla Casulo, Sonali M Smith, Ann LaCasce> ;Lancet. 2023 Aug 12
• 19 citations
  Atorvastatin for Anthracycline-Associated Cardiac Dysfunction: The STOP-CA Randomized Clinical Trial.
  Tomas G Neilan, Thiago Quinaglia, Takeshi Onoue, Syed S Mahmood, Zsofia D Drobni, Hannah K Gilman, Amanda Smith, Julius C Heemelaar, Priya Brahmbhatt, Jor Sam Ho, Supr...> ;JAMA. 2023 Aug 8
• 2 citations
  A phase 2 study of pembrolizumab after autologous stem cell transplantation in patients with T-cell non-Hodgkin lymphoma.
  Mwanasha H Merrill, Parastoo B Dahi, Robert A Redd, Mikaela M McDonough, Yi-Bin Chen, Zachariah DeFilipp, Alex F Herrera, David C Fisher, Ann S LaCasce, Oreofe O Odeji...> ;Blood. 2023 Aug 17
• The International Prognostic Index: still relevant 30 years later.
  Ann S LaCasce> ;Haematologica. 2023 Jun 1
• 5 citations
  Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study.
  Thomas M Kuczmarski, Angela C Tramontano, Lee Mozessohn, Ann S LaCasce, Lizabeth Roemer, Gregory A Abel, Oreofe O Odejide> ;The Lancet. Haematology. 2023 Jul 1
• Improved survival in cHL with novel agents.
  Reid W Merryman, Ann S LaCasce> ;Blood. 2023 Jun 1
• 1 citations
  Women in Lymphoma: A 4-year journey in promoting gender equity.
  Judith Trotman, Ann LaCasce, Wendy Osborne, Anna Steiner, Eliza Hawkes, Carla Casulo> ;Hematological Oncology. 2023 May 25
• Exploring Influencing Factors of Anxiety Improvement Following Mindfulness-Based Music Therapy in Young Adults with Cancer.
  Robert Knoerl, Emanuele Mazzola, Heather Woods, Elizabeth Buchbinder, Lindsay Frazier, Ann LaCasce, Marlise R Luskin, Carolyn S Phillips, Katherine Thornton, Donna L B...> ;Journal of Music Therapy. 2023 Jun 3
• 1 citations
  Exploring Young Adults' Perspectives of Participation in a Mindfulness-Based Music Therapy Intervention Before and During the COVID-19 Pandemic.
  Carolyn S Phillips, Julianna Bockhoff, Donna L Berry, Elizabeth Buchbinder, A Lindsay Frazier, Ann LaCasce, Jennifer Ligibel, Marlise R Luskin, Heather Woods, Robert K...> ;Journal of Adolescent and Young Adult Oncology. 2023 Aug 1
• Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma.
  Merryman, R., Michaud, L., Redd, R., Mondello, P., Park, H., Spilberg, G., Robertson, M., Taranto, E., Ahmed, G., Chase, M., Jeter, E., Ahn, I., Brown, J., Crombie, J....> ;Hemasphere. 2023 Feb 1
• 1 citations
  A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia.
  Christine E Ryan, Danielle M Brander, Paul M Barr, Svitlana Tyekucheva, Liam R Hackett, Mary C Collins, Stacey M Fernandes, Yue Ren, Yinglu Zhou, Mikaela M McDonough, ...> ;Leukemia. 2023 Apr 1
• 54 citations
  Genomic profiling for clinical decision making in lymphoid neoplasms.
  Laurence de Leval, Ash A Alizadeh, P Leif Bergsagel, Elias Campo, Andrew Davies, Ahmet Dogan, Jude Fitzgibbon, Steven M Horwitz, Ari M Melnick, William G Morice, Ryan ...> ;Blood. 2022 Nov 24
• 5 citations
  Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.
  Reid W Merryman, Robert A Redd, Eleanor Taranto, Gulrayz Ahmed, Erin Jeter, Kristin M McHugh, Jennifer R Brown, Jennifer L Crombie, Matthew S Davids, David C Fisher, A...> ;Blood Advances. 2023 Sep 12
• 4 citations
  Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance).
  Ann S LaCasce, Travis Dockter, Amy S Ruppert, Lale Kostakoglu, Heiko Schöder, Eric Hsi, Jeffrey Bogart, Bruce Cheson, Nina Wagner-Johnston, Jeremy Abramson, Kristie Bl...> ;Journal of Clinical Oncology. 2023 Feb 10
• 440 citations
  The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
  Elias Campo, Elaine S Jaffe, James R Cook, Leticia Quintanilla-Martinez, Steven H Swerdlow, Kenneth C Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, St...> ;Blood. 2022 Sep 15
• Join now to see all

Journal Articles

• Current Considerations in AYA Hodgkin Lymphoma  
  Jennifer L Crombie, Ann S LaCasce, British Journal of Haematology
• CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma  
  Mark P Chao, Sonali M Smith, Ranjana Advani, Ian Flinn, Ravindra Majeti, Nancy L Bartlett, Leslie Popplewell, Justin Kline, Nilanjan Ghosh, Ann LaCasce, The New England Journal of Medicine

Abstracts/Posters

• Brentuximab Vedotin and Nivolumab for Relapsed or Refractory Classic Hodgkin Lymphoma: Long-Term Follow-up Results from the Single-Arm Phase 1/2 Study
  Ann S. LaCasce, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Preliminary Safety and Efficacy Results from a Phase 2 Study of Acalabrutinib, Venetoclax and Obinutuzumab in Patients with Previously Untreated Chronic Lymphocytic Le...
  Ann S. LaCasce, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/7/2019

Lectures

• How to Prepare Fellows for the Transition to Academia 
  ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
• Training Program DirectorsÍ Workshop 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Training Program DirectorsÍ Workshop 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Career-Development Lunch Sessions 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Hodgkin Lymphoma: Celebrating 200 Years Since Thomas Hodgkin Entered Medicine 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Pha... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Phase 1/2 Study of Brentuximab Vedotin in Combination with Nivolumab in Patients with Relapsed or Refractory Classic Hodgkin Lymphoma: Part 3 (Concurrent Dosing) Resul... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Brentuximab Vedotin with Chemotherapy in Adolescents and Young Adults (AYA) with Stage III or IV Hodgkin Lymphoma: A Subgroup Analysis from the Phase 3 Echelon-1 Study 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• A Phase II Study of Brentuximab Vedotin Plus Adriamycin and Dacarbazine without Radiation in Non-Bulky Limited Stage Classical Hodgkin Lymphoma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Bortezomib Maintenance (BM) or Consolidation (BC) Following Aggressive Immunochemotherapy and Autologous Stem Cell Transplant (ASCT) for Untreated Mantle Cell Lymphoma... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Hematology Oncology Training Program Directors' Workshop 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• The Brigham Update in Medicine 
  Harvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 5/20/2013
• 2012 Highlights of ASH in North America (Atlanta, GA) 
  American Society of Hematology (ASH), Atlanta, Georgia - 1/27/2012
• Join now to see all

Other

• Overview of the approach to the adult survivor of classical Hodgkin lymphoma 
  LaCasce AS, Ng AK
  http://www.uptodate.com/contents/overview-of-the-approach-to-the-adult-survivor-of-classical-hodgkin
  UpToDate, Wolters Kluwer Health - 2013-03-29
• Infusion reactions to therapeutic monoclonal antibodies used for cancer therapy 
  LaCasce AS, Burstein H, Meyerhardt JA, Castells MC
  http://www.uptodate.com/contents/infusion-reactions-to-therapeutic-monoclonal-antibodies-used-for-ca
  UpToDate, Wolters Kluwer Health - 2013-03-22
• Therapeutic use and toxicity of high-dose methotrexate 
  LaCasce AS
  http://www.uptodate.com/contents/therapeutic-use-and-toxicity-of-high-dose-methotrexate
  UpToDate, Wolters Kluwer Health - 2013-03-21
• Primary lymphoma of bone 
  LaCasce AS, Freedman AS
  http://www.uptodate.com/contents/primary-lymphoma-of-bone
  UpToDate, Wolters Kluwer Health - 2012-10-09
• Join now to see all